nodes	percent_of_prediction	percent_of_DWPC	metapath
Capecitabine—colon cancer—liver cancer	0.334	0.409	CtDrD
Capecitabine—stomach cancer—liver cancer	0.272	0.332	CtDrD
Capecitabine—kidney cancer—liver cancer	0.212	0.259	CtDrD
Capecitabine—Gastritis—Epirubicin—liver cancer	9.15e-05	0.000619	CcSEcCtD
Capecitabine—Alanine aminotransferase increased—Epirubicin—liver cancer	9.12e-05	0.000617	CcSEcCtD
Capecitabine—Muscular weakness—Epirubicin—liver cancer	9.12e-05	0.000617	CcSEcCtD
Capecitabine—Cardiac arrest—Doxorubicin—liver cancer	9.1e-05	0.000616	CcSEcCtD
Capecitabine—Dizziness—Sorafenib—liver cancer	9.09e-05	0.000615	CcSEcCtD
Capecitabine—Mood swings—Doxorubicin—liver cancer	9.06e-05	0.000613	CcSEcCtD
Capecitabine—Abdominal distension—Epirubicin—liver cancer	9e-05	0.000609	CcSEcCtD
Capecitabine—Ataxia—Doxorubicin—liver cancer	9e-05	0.000609	CcSEcCtD
Capecitabine—Blood creatinine increased—Doxorubicin—liver cancer	8.96e-05	0.000607	CcSEcCtD
Capecitabine—Influenza—Epirubicin—liver cancer	8.94e-05	0.000605	CcSEcCtD
Capecitabine—Dysphagia—Epirubicin—liver cancer	8.94e-05	0.000605	CcSEcCtD
Capecitabine—Asthma—Epirubicin—liver cancer	8.94e-05	0.000605	CcSEcCtD
Capecitabine—Dehydration—Doxorubicin—liver cancer	8.9e-05	0.000602	CcSEcCtD
Capecitabine—Liver function test abnormal—Doxorubicin—liver cancer	8.83e-05	0.000598	CcSEcCtD
Capecitabine—Dry skin—Doxorubicin—liver cancer	8.77e-05	0.000593	CcSEcCtD
Capecitabine—Vomiting—Sorafenib—liver cancer	8.74e-05	0.000592	CcSEcCtD
Capecitabine—Orthostatic hypotension—Doxorubicin—liver cancer	8.74e-05	0.000591	CcSEcCtD
Capecitabine—Abdominal pain upper—Doxorubicin—liver cancer	8.74e-05	0.000591	CcSEcCtD
Capecitabine—Hypokalaemia—Doxorubicin—liver cancer	8.71e-05	0.000589	CcSEcCtD
Capecitabine—Angina pectoris—Epirubicin—liver cancer	8.7e-05	0.000589	CcSEcCtD
Capecitabine—CDA—Metabolism—GSTA2—liver cancer	8.69e-05	0.00255	CbGpPWpGaD
Capecitabine—Rash—Sorafenib—liver cancer	8.67e-05	0.000587	CcSEcCtD
Capecitabine—Dermatitis—Sorafenib—liver cancer	8.66e-05	0.000586	CcSEcCtD
Capecitabine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	8.65e-05	0.00254	CbGpPWpGaD
Capecitabine—Breast disorder—Doxorubicin—liver cancer	8.64e-05	0.000585	CcSEcCtD
Capecitabine—Toxic epidermal necrolysis—Doxorubicin—liver cancer	8.61e-05	0.000583	CcSEcCtD
Capecitabine—Aspartate aminotransferase increased—Doxorubicin—liver cancer	8.61e-05	0.000583	CcSEcCtD
Capecitabine—Headache—Sorafenib—liver cancer	8.61e-05	0.000583	CcSEcCtD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—CCND1—liver cancer	8.6e-05	0.00252	CbGpPWpGaD
Capecitabine—Bronchitis—Epirubicin—liver cancer	8.59e-05	0.000582	CcSEcCtD
Capecitabine—Nasopharyngitis—Doxorubicin—liver cancer	8.55e-05	0.000579	CcSEcCtD
Capecitabine—CYP2C9—Oxidation by Cytochrome P450—CYP2E1—liver cancer	8.53e-05	0.0025	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—CRABP1—liver cancer	8.51e-05	0.0025	CbGpPWpGaD
Capecitabine—Pancytopenia—Epirubicin—liver cancer	8.49e-05	0.000574	CcSEcCtD
Capecitabine—Gastritis—Doxorubicin—liver cancer	8.47e-05	0.000573	CcSEcCtD
Capecitabine—Muscular weakness—Doxorubicin—liver cancer	8.44e-05	0.000571	CcSEcCtD
Capecitabine—Alanine aminotransferase increased—Doxorubicin—liver cancer	8.44e-05	0.000571	CcSEcCtD
Capecitabine—CDA—Metabolism—GSTA1—liver cancer	8.38e-05	0.00246	CbGpPWpGaD
Capecitabine—Neutropenia—Epirubicin—liver cancer	8.36e-05	0.000566	CcSEcCtD
Capecitabine—Dysuria—Epirubicin—liver cancer	8.36e-05	0.000566	CcSEcCtD
Capecitabine—Abdominal distension—Doxorubicin—liver cancer	8.32e-05	0.000563	CcSEcCtD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—CDKN1A—liver cancer	8.32e-05	0.00244	CbGpPWpGaD
Capecitabine—Upper respiratory tract infection—Epirubicin—liver cancer	8.31e-05	0.000562	CcSEcCtD
Capecitabine—CDA—Metabolism—NAT2—liver cancer	8.29e-05	0.00243	CbGpPWpGaD
Capecitabine—Influenza—Doxorubicin—liver cancer	8.27e-05	0.00056	CcSEcCtD
Capecitabine—Dysphagia—Doxorubicin—liver cancer	8.27e-05	0.00056	CcSEcCtD
Capecitabine—Asthma—Doxorubicin—liver cancer	8.27e-05	0.00056	CcSEcCtD
Capecitabine—TYMP—Metabolism—CPT1B—liver cancer	8.22e-05	0.00241	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—GLUL—liver cancer	8.22e-05	0.00241	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—PCNA—liver cancer	8.22e-05	0.00241	CbGpPWpGaD
Capecitabine—Nausea—Sorafenib—liver cancer	8.17e-05	0.000553	CcSEcCtD
Capecitabine—Photosensitivity reaction—Epirubicin—liver cancer	8.16e-05	0.000552	CcSEcCtD
Capecitabine—Weight increased—Epirubicin—liver cancer	8.13e-05	0.00055	CcSEcCtD
Capecitabine—Weight decreased—Epirubicin—liver cancer	8.08e-05	0.000547	CcSEcCtD
Capecitabine—Hyperglycaemia—Epirubicin—liver cancer	8.06e-05	0.000546	CcSEcCtD
Capecitabine—Angina pectoris—Doxorubicin—liver cancer	8.05e-05	0.000545	CcSEcCtD
Capecitabine—Pneumonia—Epirubicin—liver cancer	8.01e-05	0.000542	CcSEcCtD
Capecitabine—Infestation NOS—Epirubicin—liver cancer	7.97e-05	0.000539	CcSEcCtD
Capecitabine—Infestation—Epirubicin—liver cancer	7.97e-05	0.000539	CcSEcCtD
Capecitabine—Bronchitis—Doxorubicin—liver cancer	7.95e-05	0.000538	CcSEcCtD
Capecitabine—CDA—Metabolism—ALDOB—liver cancer	7.95e-05	0.00233	CbGpPWpGaD
Capecitabine—TYMS—E2F transcription factor network—MYC—liver cancer	7.94e-05	0.00233	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—NR1H4—liver cancer	7.93e-05	0.00233	CbGpPWpGaD
Capecitabine—Stevens-Johnson syndrome—Epirubicin—liver cancer	7.9e-05	0.000535	CcSEcCtD
Capecitabine—Pancytopenia—Doxorubicin—liver cancer	7.85e-05	0.000531	CcSEcCtD
Capecitabine—Renal failure—Epirubicin—liver cancer	7.83e-05	0.00053	CcSEcCtD
Capecitabine—Neuropathy peripheral—Epirubicin—liver cancer	7.81e-05	0.000529	CcSEcCtD
Capecitabine—TYMP—Metabolism—GSTA3—liver cancer	7.79e-05	0.00229	CbGpPWpGaD
Capecitabine—Stomatitis—Epirubicin—liver cancer	7.77e-05	0.000526	CcSEcCtD
Capecitabine—Jaundice—Epirubicin—liver cancer	7.77e-05	0.000526	CcSEcCtD
Capecitabine—Urinary tract infection—Epirubicin—liver cancer	7.74e-05	0.000524	CcSEcCtD
Capecitabine—Conjunctivitis—Epirubicin—liver cancer	7.74e-05	0.000524	CcSEcCtD
Capecitabine—Neutropenia—Doxorubicin—liver cancer	7.73e-05	0.000523	CcSEcCtD
Capecitabine—Dysuria—Doxorubicin—liver cancer	7.73e-05	0.000523	CcSEcCtD
Capecitabine—Upper respiratory tract infection—Doxorubicin—liver cancer	7.68e-05	0.00052	CcSEcCtD
Capecitabine—Haematuria—Epirubicin—liver cancer	7.6e-05	0.000514	CcSEcCtD
Capecitabine—CDA—Metabolism—CRABP1—liver cancer	7.58e-05	0.00222	CbGpPWpGaD
Capecitabine—Photosensitivity reaction—Doxorubicin—liver cancer	7.55e-05	0.000511	CcSEcCtD
Capecitabine—Hepatobiliary disease—Epirubicin—liver cancer	7.54e-05	0.00051	CcSEcCtD
Capecitabine—TYMS—G1/S Transition—CDKN1B—liver cancer	7.53e-05	0.00221	CbGpPWpGaD
Capecitabine—Weight increased—Doxorubicin—liver cancer	7.52e-05	0.000509	CcSEcCtD
Capecitabine—Epistaxis—Epirubicin—liver cancer	7.52e-05	0.000509	CcSEcCtD
Capecitabine—TYMS—Circadian rythm related genes—PPARA—liver cancer	7.49e-05	0.0022	CbGpPWpGaD
Capecitabine—Weight decreased—Doxorubicin—liver cancer	7.48e-05	0.000506	CcSEcCtD
Capecitabine—Hyperglycaemia—Doxorubicin—liver cancer	7.46e-05	0.000505	CcSEcCtD
Capecitabine—Agranulocytosis—Epirubicin—liver cancer	7.44e-05	0.000503	CcSEcCtD
Capecitabine—DPYD—Metabolism—HPGDS—liver cancer	7.44e-05	0.00218	CbGpPWpGaD
Capecitabine—Pneumonia—Doxorubicin—liver cancer	7.42e-05	0.000502	CcSEcCtD
Capecitabine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	7.4e-05	0.00217	CbGpPWpGaD
Capecitabine—Infestation—Doxorubicin—liver cancer	7.37e-05	0.000499	CcSEcCtD
Capecitabine—Infestation NOS—Doxorubicin—liver cancer	7.37e-05	0.000499	CcSEcCtD
Capecitabine—Stevens-Johnson syndrome—Doxorubicin—liver cancer	7.31e-05	0.000495	CcSEcCtD
Capecitabine—Bradycardia—Epirubicin—liver cancer	7.28e-05	0.000493	CcSEcCtD
Capecitabine—Renal failure—Doxorubicin—liver cancer	7.25e-05	0.00049	CcSEcCtD
Capecitabine—Neuropathy peripheral—Doxorubicin—liver cancer	7.23e-05	0.000489	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—MAPK14—liver cancer	7.21e-05	0.00212	CbGpPWpGaD
Capecitabine—Haemoglobin—Epirubicin—liver cancer	7.19e-05	0.000487	CcSEcCtD
Capecitabine—CYP2C9—Arachidonic acid metabolism—CYP1A1—liver cancer	7.19e-05	0.00211	CbGpPWpGaD
Capecitabine—Jaundice—Doxorubicin—liver cancer	7.19e-05	0.000486	CcSEcCtD
Capecitabine—Stomatitis—Doxorubicin—liver cancer	7.19e-05	0.000486	CcSEcCtD
Capecitabine—Rhinitis—Epirubicin—liver cancer	7.17e-05	0.000485	CcSEcCtD
Capecitabine—Conjunctivitis—Doxorubicin—liver cancer	7.17e-05	0.000485	CcSEcCtD
Capecitabine—Urinary tract infection—Doxorubicin—liver cancer	7.17e-05	0.000485	CcSEcCtD
Capecitabine—TYMS—Mitotic G1-G1/S phases—CDKN2A—liver cancer	7.17e-05	0.0021	CbGpPWpGaD
Capecitabine—Hepatitis—Epirubicin—liver cancer	7.15e-05	0.000484	CcSEcCtD
Capecitabine—Haemorrhage—Epirubicin—liver cancer	7.15e-05	0.000484	CcSEcCtD
Capecitabine—TYMP—Metabolism—GSTA4—liver cancer	7.13e-05	0.00209	CbGpPWpGaD
Capecitabine—Hypoaesthesia—Epirubicin—liver cancer	7.12e-05	0.000482	CcSEcCtD
Capecitabine—Pharyngitis—Epirubicin—liver cancer	7.1e-05	0.00048	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—ESR1—liver cancer	7.07e-05	0.00207	CbGpPWpGaD
Capecitabine—Urinary tract disorder—Epirubicin—liver cancer	7.06e-05	0.000478	CcSEcCtD
Capecitabine—Oedema peripheral—Epirubicin—liver cancer	7.05e-05	0.000477	CcSEcCtD
Capecitabine—Haematuria—Doxorubicin—liver cancer	7.03e-05	0.000476	CcSEcCtD
Capecitabine—Connective tissue disorder—Epirubicin—liver cancer	7.03e-05	0.000476	CcSEcCtD
Capecitabine—Urethral disorder—Epirubicin—liver cancer	7.01e-05	0.000475	CcSEcCtD
Capecitabine—CYP2C9—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	7.01e-05	0.00206	CbGpPWpGaD
Capecitabine—Hepatobiliary disease—Doxorubicin—liver cancer	6.97e-05	0.000472	CcSEcCtD
Capecitabine—Epistaxis—Doxorubicin—liver cancer	6.95e-05	0.000471	CcSEcCtD
Capecitabine—TYMS—G1/S Transition—CDKN1A—liver cancer	6.95e-05	0.00204	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—GSTA2—liver cancer	6.95e-05	0.00204	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—UGDH—liver cancer	6.94e-05	0.00204	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—MYC—liver cancer	6.9e-05	0.00202	CbGpPWpGaD
Capecitabine—Visual impairment—Epirubicin—liver cancer	6.89e-05	0.000467	CcSEcCtD
Capecitabine—Agranulocytosis—Doxorubicin—liver cancer	6.88e-05	0.000466	CcSEcCtD
Capecitabine—CYP2C9—Biological oxidations—NR1H4—liver cancer	6.84e-05	0.00201	CbGpPWpGaD
Capecitabine—Erythema multiforme—Epirubicin—liver cancer	6.76e-05	0.000458	CcSEcCtD
Capecitabine—Bradycardia—Doxorubicin—liver cancer	6.74e-05	0.000456	CcSEcCtD
Capecitabine—CYP2C9—Biological oxidations—GSTA3—liver cancer	6.72e-05	0.00197	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—GSTA1—liver cancer	6.7e-05	0.00197	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—APC—liver cancer	6.69e-05	0.00196	CbGpPWpGaD
Capecitabine—Eye disorder—Epirubicin—liver cancer	6.68e-05	0.000452	CcSEcCtD
Capecitabine—Tinnitus—Epirubicin—liver cancer	6.67e-05	0.000451	CcSEcCtD
Capecitabine—Haemoglobin—Doxorubicin—liver cancer	6.65e-05	0.00045	CcSEcCtD
Capecitabine—Cardiac disorder—Epirubicin—liver cancer	6.64e-05	0.000449	CcSEcCtD
Capecitabine—Flushing—Epirubicin—liver cancer	6.64e-05	0.000449	CcSEcCtD
Capecitabine—Rhinitis—Doxorubicin—liver cancer	6.63e-05	0.000449	CcSEcCtD
Capecitabine—CYP2C9—Metapathway biotransformation—GSTA3—liver cancer	6.63e-05	0.00194	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—NAT2—liver cancer	6.63e-05	0.00194	CbGpPWpGaD
Capecitabine—CDA—Metabolism—HPGDS—liver cancer	6.63e-05	0.00194	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PSMA4—liver cancer	6.63e-05	0.00194	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PSMD10—liver cancer	6.63e-05	0.00194	CbGpPWpGaD
Capecitabine—Haemorrhage—Doxorubicin—liver cancer	6.62e-05	0.000448	CcSEcCtD
Capecitabine—Hepatitis—Doxorubicin—liver cancer	6.62e-05	0.000448	CcSEcCtD
Capecitabine—Hypoaesthesia—Doxorubicin—liver cancer	6.58e-05	0.000446	CcSEcCtD
Capecitabine—Pharyngitis—Doxorubicin—liver cancer	6.57e-05	0.000445	CcSEcCtD
Capecitabine—CES1—NRF2 pathway—TGFB1—liver cancer	6.56e-05	0.00192	CbGpPWpGaD
Capecitabine—Urinary tract disorder—Doxorubicin—liver cancer	6.54e-05	0.000442	CcSEcCtD
Capecitabine—TYMS—Metabolism—EPT1—liver cancer	6.53e-05	0.00191	CbGpPWpGaD
Capecitabine—Oedema peripheral—Doxorubicin—liver cancer	6.52e-05	0.000441	CcSEcCtD
Capecitabine—Connective tissue disorder—Doxorubicin—liver cancer	6.5e-05	0.00044	CcSEcCtD
Capecitabine—Angiopathy—Epirubicin—liver cancer	6.49e-05	0.000439	CcSEcCtD
Capecitabine—Urethral disorder—Doxorubicin—liver cancer	6.49e-05	0.000439	CcSEcCtD
Capecitabine—Immune system disorder—Epirubicin—liver cancer	6.46e-05	0.000437	CcSEcCtD
Capecitabine—DPYD—Metabolism—GOT2—liver cancer	6.45e-05	0.00189	CbGpPWpGaD
Capecitabine—Mediastinal disorder—Epirubicin—liver cancer	6.45e-05	0.000436	CcSEcCtD
Capecitabine—Chills—Epirubicin—liver cancer	6.42e-05	0.000434	CcSEcCtD
Capecitabine—Arrhythmia—Epirubicin—liver cancer	6.39e-05	0.000432	CcSEcCtD
Capecitabine—Visual impairment—Doxorubicin—liver cancer	6.38e-05	0.000432	CcSEcCtD
Capecitabine—TYMP—Metabolism—ALDOB—liver cancer	6.35e-05	0.00186	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—CDKN1B—liver cancer	6.35e-05	0.00186	CbGpPWpGaD
Capecitabine—Alopecia—Epirubicin—liver cancer	6.32e-05	0.000428	CcSEcCtD
Capecitabine—TYMS—Cell Cycle, Mitotic—PSMA4—liver cancer	6.29e-05	0.00184	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—PSMD10—liver cancer	6.29e-05	0.00184	CbGpPWpGaD
Capecitabine—Mental disorder—Epirubicin—liver cancer	6.27e-05	0.000424	CcSEcCtD
Capecitabine—Erythema multiforme—Doxorubicin—liver cancer	6.26e-05	0.000423	CcSEcCtD
Capecitabine—Erythema—Epirubicin—liver cancer	6.23e-05	0.000421	CcSEcCtD
Capecitabine—Malnutrition—Epirubicin—liver cancer	6.23e-05	0.000421	CcSEcCtD
Capecitabine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	6.21e-05	0.00182	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—PPARG—liver cancer	6.19e-05	0.00182	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—TAT—liver cancer	6.19e-05	0.00182	CbGpPWpGaD
Capecitabine—Eye disorder—Doxorubicin—liver cancer	6.18e-05	0.000419	CcSEcCtD
Capecitabine—Tinnitus—Doxorubicin—liver cancer	6.17e-05	0.000418	CcSEcCtD
Capecitabine—CYP2C9—Biological oxidations—GSTA4—liver cancer	6.15e-05	0.0018	CbGpPWpGaD
Capecitabine—Cardiac disorder—Doxorubicin—liver cancer	6.14e-05	0.000416	CcSEcCtD
Capecitabine—Flushing—Doxorubicin—liver cancer	6.14e-05	0.000416	CcSEcCtD
Capecitabine—Flatulence—Epirubicin—liver cancer	6.14e-05	0.000415	CcSEcCtD
Capecitabine—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—liver cancer	6.13e-05	0.0018	CbGpPWpGaD
Capecitabine—Dysgeusia—Epirubicin—liver cancer	6.1e-05	0.000413	CcSEcCtD
Capecitabine—CYP2C9—Metapathway biotransformation—GSTA4—liver cancer	6.06e-05	0.00178	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—CYP2E1—liver cancer	6.06e-05	0.00178	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—CRABP1—liver cancer	6.06e-05	0.00178	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—CCND1—liver cancer	6.05e-05	0.00178	CbGpPWpGaD
Capecitabine—Back pain—Epirubicin—liver cancer	6.02e-05	0.000408	CcSEcCtD
Capecitabine—Angiopathy—Doxorubicin—liver cancer	6e-05	0.000406	CcSEcCtD
Capecitabine—CYP2C9—Biological oxidations—GSTA2—liver cancer	5.99e-05	0.00176	CbGpPWpGaD
Capecitabine—Muscle spasms—Epirubicin—liver cancer	5.99e-05	0.000405	CcSEcCtD
Capecitabine—Immune system disorder—Doxorubicin—liver cancer	5.98e-05	0.000405	CcSEcCtD
Capecitabine—Mediastinal disorder—Doxorubicin—liver cancer	5.96e-05	0.000404	CcSEcCtD
Capecitabine—Chills—Doxorubicin—liver cancer	5.94e-05	0.000402	CcSEcCtD
Capecitabine—Arrhythmia—Doxorubicin—liver cancer	5.91e-05	0.0004	CcSEcCtD
Capecitabine—CDA—Metabolism—PSMA4—liver cancer	5.91e-05	0.00173	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PSMD10—liver cancer	5.91e-05	0.00173	CbGpPWpGaD
Capecitabine—Vision blurred—Epirubicin—liver cancer	5.87e-05	0.000397	CcSEcCtD
Capecitabine—TYMS—Mitotic G1-G1/S phases—CDKN1A—liver cancer	5.86e-05	0.00172	CbGpPWpGaD
Capecitabine—Alopecia—Doxorubicin—liver cancer	5.85e-05	0.000396	CcSEcCtD
Capecitabine—Mental disorder—Doxorubicin—liver cancer	5.8e-05	0.000392	CcSEcCtD
Capecitabine—CYP2C9—Biological oxidations—GSTA1—liver cancer	5.78e-05	0.0017	CbGpPWpGaD
Capecitabine—Ill-defined disorder—Epirubicin—liver cancer	5.78e-05	0.000391	CcSEcCtD
Capecitabine—TYMS—G1/S Transition—MYC—liver cancer	5.76e-05	0.00169	CbGpPWpGaD
Capecitabine—Erythema—Doxorubicin—liver cancer	5.76e-05	0.00039	CcSEcCtD
Capecitabine—Malnutrition—Doxorubicin—liver cancer	5.76e-05	0.00039	CcSEcCtD
Capecitabine—Anaemia—Epirubicin—liver cancer	5.75e-05	0.000389	CcSEcCtD
Capecitabine—CDA—Metabolism—GOT2—liver cancer	5.75e-05	0.00169	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—NAT2—liver cancer	5.71e-05	0.00168	CbGpPWpGaD
Capecitabine—Flatulence—Doxorubicin—liver cancer	5.68e-05	0.000384	CcSEcCtD
Capecitabine—DPYD—Metabolism—CYCS—liver cancer	5.67e-05	0.00166	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—TP53—liver cancer	5.67e-05	0.00166	CbGpPWpGaD
Capecitabine—Dysgeusia—Doxorubicin—liver cancer	5.64e-05	0.000382	CcSEcCtD
Capecitabine—CYP2C9—Metapathway biotransformation—NAT2—liver cancer	5.64e-05	0.00165	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—PSMD10—liver cancer	5.62e-05	0.00165	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—PSMA4—liver cancer	5.62e-05	0.00165	CbGpPWpGaD
Capecitabine—Malaise—Epirubicin—liver cancer	5.61e-05	0.00038	CcSEcCtD
Capecitabine—Vertigo—Epirubicin—liver cancer	5.59e-05	0.000379	CcSEcCtD
Capecitabine—Syncope—Epirubicin—liver cancer	5.58e-05	0.000378	CcSEcCtD
Capecitabine—TYMS—Circadian rythm related genes—SERPINE1—liver cancer	5.58e-05	0.00164	CbGpPWpGaD
Capecitabine—Leukopenia—Epirubicin—liver cancer	5.57e-05	0.000377	CcSEcCtD
Capecitabine—Back pain—Doxorubicin—liver cancer	5.57e-05	0.000377	CcSEcCtD
Capecitabine—DPYD—Metabolism—GGT1—liver cancer	5.57e-05	0.00163	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—GOT1—liver cancer	5.57e-05	0.00163	CbGpPWpGaD
Capecitabine—Muscle spasms—Doxorubicin—liver cancer	5.54e-05	0.000375	CcSEcCtD
Capecitabine—Palpitations—Epirubicin—liver cancer	5.5e-05	0.000372	CcSEcCtD
Capecitabine—Loss of consciousness—Epirubicin—liver cancer	5.47e-05	0.00037	CcSEcCtD
Capecitabine—Cough—Epirubicin—liver cancer	5.43e-05	0.000368	CcSEcCtD
Capecitabine—Vision blurred—Doxorubicin—liver cancer	5.43e-05	0.000367	CcSEcCtD
Capecitabine—CDA—Metabolism—CYP2E1—liver cancer	5.4e-05	0.00159	CbGpPWpGaD
Capecitabine—Hypertension—Epirubicin—liver cancer	5.38e-05	0.000364	CcSEcCtD
Capecitabine—Ill-defined disorder—Doxorubicin—liver cancer	5.35e-05	0.000362	CcSEcCtD
Capecitabine—Anaemia—Doxorubicin—liver cancer	5.32e-05	0.00036	CcSEcCtD
Capecitabine—Chest pain—Epirubicin—liver cancer	5.3e-05	0.000359	CcSEcCtD
Capecitabine—Arthralgia—Epirubicin—liver cancer	5.3e-05	0.000359	CcSEcCtD
Capecitabine—Myalgia—Epirubicin—liver cancer	5.3e-05	0.000359	CcSEcCtD
Capecitabine—TYMP—Metabolism—HPGDS—liver cancer	5.3e-05	0.00155	CbGpPWpGaD
Capecitabine—Anxiety—Epirubicin—liver cancer	5.28e-05	0.000358	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	5.26e-05	0.000356	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	5.25e-05	0.00154	CbGpPWpGaD
Capecitabine—Discomfort—Epirubicin—liver cancer	5.24e-05	0.000354	CcSEcCtD
Capecitabine—Malaise—Doxorubicin—liver cancer	5.2e-05	0.000352	CcSEcCtD
Capecitabine—Dry mouth—Epirubicin—liver cancer	5.18e-05	0.000351	CcSEcCtD
Capecitabine—Vertigo—Doxorubicin—liver cancer	5.18e-05	0.00035	CcSEcCtD
Capecitabine—Syncope—Doxorubicin—liver cancer	5.17e-05	0.00035	CcSEcCtD
Capecitabine—Leukopenia—Doxorubicin—liver cancer	5.16e-05	0.000349	CcSEcCtD
Capecitabine—Confusional state—Epirubicin—liver cancer	5.12e-05	0.000347	CcSEcCtD
Capecitabine—Palpitations—Doxorubicin—liver cancer	5.09e-05	0.000345	CcSEcCtD
Capecitabine—Oedema—Epirubicin—liver cancer	5.08e-05	0.000344	CcSEcCtD
Capecitabine—Loss of consciousness—Doxorubicin—liver cancer	5.06e-05	0.000343	CcSEcCtD
Capecitabine—CDA—Metabolism—CYCS—liver cancer	5.05e-05	0.00148	CbGpPWpGaD
Capecitabine—Infection—Epirubicin—liver cancer	5.05e-05	0.000342	CcSEcCtD
Capecitabine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	5.04e-05	0.00148	CbGpPWpGaD
Capecitabine—Cough—Doxorubicin—liver cancer	5.03e-05	0.00034	CcSEcCtD
Capecitabine—Shock—Epirubicin—liver cancer	5e-05	0.000338	CcSEcCtD
Capecitabine—DPYD—Metabolism—GSTP1—liver cancer	5e-05	0.00147	CbGpPWpGaD
Capecitabine—Nervous system disorder—Epirubicin—liver cancer	4.98e-05	0.000337	CcSEcCtD
Capecitabine—Thrombocytopenia—Epirubicin—liver cancer	4.98e-05	0.000337	CcSEcCtD
Capecitabine—Hypertension—Doxorubicin—liver cancer	4.97e-05	0.000337	CcSEcCtD
Capecitabine—CDA—Metabolism—GGT1—liver cancer	4.96e-05	0.00146	CbGpPWpGaD
Capecitabine—CDA—Metabolism—GOT1—liver cancer	4.96e-05	0.00146	CbGpPWpGaD
Capecitabine—Tachycardia—Epirubicin—liver cancer	4.96e-05	0.000336	CcSEcCtD
Capecitabine—Skin disorder—Epirubicin—liver cancer	4.94e-05	0.000334	CcSEcCtD
Capecitabine—DPYD—Metabolism—HMOX1—liver cancer	4.93e-05	0.00145	CbGpPWpGaD
Capecitabine—Hyperhidrosis—Epirubicin—liver cancer	4.91e-05	0.000332	CcSEcCtD
Capecitabine—Chest pain—Doxorubicin—liver cancer	4.9e-05	0.000332	CcSEcCtD
Capecitabine—Myalgia—Doxorubicin—liver cancer	4.9e-05	0.000332	CcSEcCtD
Capecitabine—Arthralgia—Doxorubicin—liver cancer	4.9e-05	0.000332	CcSEcCtD
Capecitabine—Anxiety—Doxorubicin—liver cancer	4.89e-05	0.000331	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	4.87e-05	0.00033	CcSEcCtD
Capecitabine—TYMS—Mitotic G1-G1/S phases—MYC—liver cancer	4.86e-05	0.00142	CbGpPWpGaD
Capecitabine—Discomfort—Doxorubicin—liver cancer	4.85e-05	0.000328	CcSEcCtD
Capecitabine—Anorexia—Epirubicin—liver cancer	4.84e-05	0.000328	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	4.81e-05	0.00141	CbGpPWpGaD
Capecitabine—Dry mouth—Doxorubicin—liver cancer	4.8e-05	0.000325	CcSEcCtD
Capecitabine—CYP2C9—Metapathway biotransformation—GPX3—liver cancer	4.79e-05	0.00141	CbGpPWpGaD
Capecitabine—Hypotension—Epirubicin—liver cancer	4.75e-05	0.000321	CcSEcCtD
Capecitabine—Confusional state—Doxorubicin—liver cancer	4.74e-05	0.000321	CcSEcCtD
Capecitabine—TYMP—Metabolism—PSMD10—liver cancer	4.72e-05	0.00139	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PSMA4—liver cancer	4.72e-05	0.00139	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	4.71e-05	0.00138	CbGpPWpGaD
Capecitabine—Oedema—Doxorubicin—liver cancer	4.7e-05	0.000318	CcSEcCtD
Capecitabine—Infection—Doxorubicin—liver cancer	4.67e-05	0.000316	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Epirubicin—liver cancer	4.63e-05	0.000313	CcSEcCtD
Capecitabine—Shock—Doxorubicin—liver cancer	4.63e-05	0.000313	CcSEcCtD
Capecitabine—Nervous system disorder—Doxorubicin—liver cancer	4.61e-05	0.000312	CcSEcCtD
Capecitabine—Thrombocytopenia—Doxorubicin—liver cancer	4.6e-05	0.000312	CcSEcCtD
Capecitabine—Insomnia—Epirubicin—liver cancer	4.6e-05	0.000311	CcSEcCtD
Capecitabine—DPYD—Metabolism—GSTM1—liver cancer	4.59e-05	0.00135	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—GOT2—liver cancer	4.59e-05	0.00135	CbGpPWpGaD
Capecitabine—Tachycardia—Doxorubicin—liver cancer	4.59e-05	0.000311	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	4.59e-05	0.00135	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	4.58e-05	0.00134	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—HPGDS—liver cancer	4.57e-05	0.00134	CbGpPWpGaD
Capecitabine—Skin disorder—Doxorubicin—liver cancer	4.57e-05	0.000309	CcSEcCtD
Capecitabine—Paraesthesia—Epirubicin—liver cancer	4.56e-05	0.000309	CcSEcCtD
Capecitabine—Hyperhidrosis—Doxorubicin—liver cancer	4.55e-05	0.000308	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	4.54e-05	0.00133	CbGpPWpGaD
Capecitabine—Dyspnoea—Epirubicin—liver cancer	4.53e-05	0.000307	CcSEcCtD
Capecitabine—Anorexia—Doxorubicin—liver cancer	4.48e-05	0.000303	CcSEcCtD
Capecitabine—Dyspepsia—Epirubicin—liver cancer	4.47e-05	0.000303	CcSEcCtD
Capecitabine—CDA—Metabolism—GSTP1—liver cancer	4.46e-05	0.00131	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	4.44e-05	0.0013	CbGpPWpGaD
Capecitabine—Decreased appetite—Epirubicin—liver cancer	4.42e-05	0.000299	CcSEcCtD
Capecitabine—CDA—Metabolism—HMOX1—liver cancer	4.39e-05	0.00129	CbGpPWpGaD
Capecitabine—Hypotension—Doxorubicin—liver cancer	4.39e-05	0.000297	CcSEcCtD
Capecitabine—TYMS—Circadian rythm related genes—JUN—liver cancer	4.39e-05	0.00129	CbGpPWpGaD
Capecitabine—Gastrointestinal disorder—Epirubicin—liver cancer	4.39e-05	0.000297	CcSEcCtD
Capecitabine—Fatigue—Epirubicin—liver cancer	4.38e-05	0.000297	CcSEcCtD
Capecitabine—DPYD—Metabolism—CYP1A1—liver cancer	4.35e-05	0.00128	CbGpPWpGaD
Capecitabine—Pain—Epirubicin—liver cancer	4.35e-05	0.000294	CcSEcCtD
Capecitabine—Constipation—Epirubicin—liver cancer	4.35e-05	0.000294	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	4.33e-05	0.00127	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—CYP2E1—liver cancer	4.32e-05	0.00127	CbGpPWpGaD
Capecitabine—Musculoskeletal discomfort—Doxorubicin—liver cancer	4.28e-05	0.00029	CcSEcCtD
Capecitabine—Insomnia—Doxorubicin—liver cancer	4.25e-05	0.000288	CcSEcCtD
Capecitabine—TYMS—Cell Cycle, Mitotic—H2AFX—liver cancer	4.25e-05	0.00125	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—EPT1—liver cancer	4.22e-05	0.00124	CbGpPWpGaD
Capecitabine—Paraesthesia—Doxorubicin—liver cancer	4.22e-05	0.000286	CcSEcCtD
Capecitabine—TYMS—Metabolism—CPT1B—liver cancer	4.21e-05	0.00123	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GLUL—liver cancer	4.21e-05	0.00123	CbGpPWpGaD
Capecitabine—Dyspnoea—Doxorubicin—liver cancer	4.19e-05	0.000284	CcSEcCtD
Capecitabine—Feeling abnormal—Epirubicin—liver cancer	4.19e-05	0.000283	CcSEcCtD
Capecitabine—TYMS—Circadian rythm related genes—MAPK8—liver cancer	4.16e-05	0.00122	CbGpPWpGaD
Capecitabine—Gastrointestinal pain—Epirubicin—liver cancer	4.16e-05	0.000281	CcSEcCtD
Capecitabine—Dyspepsia—Doxorubicin—liver cancer	4.14e-05	0.00028	CcSEcCtD
Capecitabine—CDA—Metabolism—GSTM1—liver cancer	4.09e-05	0.0012	CbGpPWpGaD
Capecitabine—Decreased appetite—Doxorubicin—liver cancer	4.09e-05	0.000277	CcSEcCtD
Capecitabine—DPYD—Metabolism—MTHFR—liver cancer	4.06e-05	0.00119	CbGpPWpGaD
Capecitabine—Gastrointestinal disorder—Doxorubicin—liver cancer	4.06e-05	0.000275	CcSEcCtD
Capecitabine—TYMS—Metabolism—NR1H4—liver cancer	4.06e-05	0.00119	CbGpPWpGaD
Capecitabine—Fatigue—Doxorubicin—liver cancer	4.05e-05	0.000274	CcSEcCtD
Capecitabine—TYMP—Metabolism—CYCS—liver cancer	4.04e-05	0.00119	CbGpPWpGaD
Capecitabine—Urticaria—Epirubicin—liver cancer	4.04e-05	0.000273	CcSEcCtD
Capecitabine—Pain—Doxorubicin—liver cancer	4.02e-05	0.000272	CcSEcCtD
Capecitabine—Constipation—Doxorubicin—liver cancer	4.02e-05	0.000272	CcSEcCtD
Capecitabine—Body temperature increased—Epirubicin—liver cancer	4.02e-05	0.000272	CcSEcCtD
Capecitabine—Abdominal pain—Epirubicin—liver cancer	4.02e-05	0.000272	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	4e-05	0.00117	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GSTA3—liver cancer	3.99e-05	0.00117	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PPARA—liver cancer	3.98e-05	0.00117	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—PCNA—liver cancer	3.98e-05	0.00117	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—GGT1—liver cancer	3.97e-05	0.00116	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—GOT1—liver cancer	3.97e-05	0.00116	CbGpPWpGaD
Capecitabine—CDA—Metabolism—CYP1A1—liver cancer	3.88e-05	0.00114	CbGpPWpGaD
Capecitabine—Feeling abnormal—Doxorubicin—liver cancer	3.87e-05	0.000262	CcSEcCtD
Capecitabine—Gastrointestinal pain—Doxorubicin—liver cancer	3.84e-05	0.00026	CcSEcCtD
Capecitabine—TYMS—Cell Cycle—H2AFX—liver cancer	3.8e-05	0.00111	CbGpPWpGaD
Capecitabine—Hypersensitivity—Epirubicin—liver cancer	3.74e-05	0.000253	CcSEcCtD
Capecitabine—Urticaria—Doxorubicin—liver cancer	3.74e-05	0.000253	CcSEcCtD
Capecitabine—CYP2C9—Biological oxidations—CYP2E1—liver cancer	3.72e-05	0.00109	CbGpPWpGaD
Capecitabine—Body temperature increased—Doxorubicin—liver cancer	3.72e-05	0.000252	CcSEcCtD
Capecitabine—Abdominal pain—Doxorubicin—liver cancer	3.72e-05	0.000252	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	3.68e-05	0.00108	CbGpPWpGaD
Capecitabine—CYP2C9—Metapathway biotransformation—CYP2E1—liver cancer	3.67e-05	0.00108	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	3.67e-05	0.00108	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GSTA4—liver cancer	3.65e-05	0.00107	CbGpPWpGaD
Capecitabine—Asthenia—Epirubicin—liver cancer	3.65e-05	0.000247	CcSEcCtD
Capecitabine—CDA—Metabolism—MTHFR—liver cancer	3.62e-05	0.00106	CbGpPWpGaD
Capecitabine—Pruritus—Epirubicin—liver cancer	3.6e-05	0.000243	CcSEcCtD
Capecitabine—TYMP—Metabolism—GSTP1—liver cancer	3.56e-05	0.00104	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—PCNA—liver cancer	3.56e-05	0.00104	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GSTA2—liver cancer	3.55e-05	0.00104	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PPARA—liver cancer	3.55e-05	0.00104	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—HMOX1—liver cancer	3.51e-05	0.00103	CbGpPWpGaD
Capecitabine—Diarrhoea—Epirubicin—liver cancer	3.48e-05	0.000235	CcSEcCtD
Capecitabine—Hypersensitivity—Doxorubicin—liver cancer	3.46e-05	0.000234	CcSEcCtD
Capecitabine—TYMS—Cell Cycle—TERT—liver cancer	3.43e-05	0.00101	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GSTA1—liver cancer	3.43e-05	0.00101	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	3.43e-05	0.00101	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—GGT1—liver cancer	3.42e-05	0.001	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PIK3CG—liver cancer	3.41e-05	0.001	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	3.4e-05	0.000997	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—NAT2—liver cancer	3.39e-05	0.000995	CbGpPWpGaD
Capecitabine—Asthenia—Doxorubicin—liver cancer	3.37e-05	0.000228	CcSEcCtD
Capecitabine—Dizziness—Epirubicin—liver cancer	3.36e-05	0.000227	CcSEcCtD
Capecitabine—Pruritus—Doxorubicin—liver cancer	3.33e-05	0.000225	CcSEcCtD
Capecitabine—DPYD—Metabolism—PPARG—liver cancer	3.29e-05	0.000966	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—GSTM1—liver cancer	3.27e-05	0.00096	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ALDOB—liver cancer	3.25e-05	0.000954	CbGpPWpGaD
Capecitabine—Vomiting—Epirubicin—liver cancer	3.23e-05	0.000219	CcSEcCtD
Capecitabine—Diarrhoea—Doxorubicin—liver cancer	3.22e-05	0.000218	CcSEcCtD
Capecitabine—Rash—Epirubicin—liver cancer	3.2e-05	0.000217	CcSEcCtD
Capecitabine—Dermatitis—Epirubicin—liver cancer	3.2e-05	0.000217	CcSEcCtD
Capecitabine—Headache—Epirubicin—liver cancer	3.18e-05	0.000215	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	3.12e-05	0.000916	CbGpPWpGaD
Capecitabine—Dizziness—Doxorubicin—liver cancer	3.11e-05	0.00021	CcSEcCtD
Capecitabine—TYMP—Metabolism—CYP1A1—liver cancer	3.1e-05	0.00091	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CRABP1—liver cancer	3.1e-05	0.00091	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—GSTP1—liver cancer	3.07e-05	0.000901	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PIK3CG—liver cancer	3.04e-05	0.000892	CbGpPWpGaD
Capecitabine—CYP2C9—Metapathway biotransformation—GSTP1—liver cancer	3.03e-05	0.000889	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	3.02e-05	0.000886	CbGpPWpGaD
Capecitabine—Nausea—Epirubicin—liver cancer	3.02e-05	0.000204	CcSEcCtD
Capecitabine—DPYD—Metabolism—PIK3CD—liver cancer	3e-05	0.00088	CbGpPWpGaD
Capecitabine—Vomiting—Doxorubicin—liver cancer	2.99e-05	0.000202	CcSEcCtD
Capecitabine—Rash—Doxorubicin—liver cancer	2.96e-05	0.000201	CcSEcCtD
Capecitabine—Dermatitis—Doxorubicin—liver cancer	2.96e-05	0.0002	CcSEcCtD
Capecitabine—DPYD—Metabolism—ALB—liver cancer	2.96e-05	0.000868	CbGpPWpGaD
Capecitabine—Headache—Doxorubicin—liver cancer	2.95e-05	0.000199	CcSEcCtD
Capecitabine—CDA—Metabolism—PPARG—liver cancer	2.93e-05	0.000861	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—TP53—liver cancer	2.9e-05	0.000851	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—MTHFR—liver cancer	2.89e-05	0.000849	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PPARA—liver cancer	2.84e-05	0.000833	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—GSTM1—liver cancer	2.82e-05	0.000828	CbGpPWpGaD
Capecitabine—Nausea—Doxorubicin—liver cancer	2.79e-05	0.000189	CcSEcCtD
Capecitabine—CYP2C9—Metapathway biotransformation—GSTM1—liver cancer	2.78e-05	0.000817	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	2.72e-05	0.000799	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—HPGDS—liver cancer	2.71e-05	0.000795	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—CYP1A1—liver cancer	2.68e-05	0.000785	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PIK3CD—liver cancer	2.67e-05	0.000784	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—IL6—liver cancer	2.65e-05	0.000779	CbGpPWpGaD
Capecitabine—CYP2C9—Metapathway biotransformation—CYP1A1—liver cancer	2.64e-05	0.000774	CbGpPWpGaD
Capecitabine—CDA—Metabolism—ALB—liver cancer	2.64e-05	0.000774	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—CDKN2A—liver cancer	2.63e-05	0.000771	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	2.62e-05	0.00077	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PIK3CB—liver cancer	2.61e-05	0.000767	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	2.55e-05	0.000748	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PIK3CG—liver cancer	2.43e-05	0.000713	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PSMA4—liver cancer	2.42e-05	0.000709	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PSMD10—liver cancer	2.42e-05	0.000709	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GOT2—liver cancer	2.35e-05	0.000689	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CDKN2A—liver cancer	2.35e-05	0.000689	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PPARG—liver cancer	2.35e-05	0.000688	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PIK3CB—liver cancer	2.33e-05	0.000683	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—CDKN1B—liver cancer	2.33e-05	0.000683	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—CCND1—liver cancer	2.22e-05	0.000651	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CYP2E1—liver cancer	2.21e-05	0.000648	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—CDKN1A—liver cancer	2.15e-05	0.00063	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PIK3CD—liver cancer	2.14e-05	0.000627	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—ALB—liver cancer	2.11e-05	0.000619	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CDKN1B—liver cancer	2.08e-05	0.000611	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CYCS—liver cancer	2.07e-05	0.000606	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GOT1—liver cancer	2.03e-05	0.000595	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GGT1—liver cancer	2.03e-05	0.000595	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	2.01e-05	0.000589	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—UGDH—liver cancer	2e-05	0.000587	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CCND1—liver cancer	1.99e-05	0.000582	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CDKN1A—liver cancer	1.92e-05	0.000563	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—EPT1—liver cancer	1.88e-05	0.000552	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PIK3CB—liver cancer	1.86e-05	0.000546	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GSTP1—liver cancer	1.82e-05	0.000535	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—HMOX1—liver cancer	1.8e-05	0.000527	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—TAT—liver cancer	1.78e-05	0.000523	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—MYC—liver cancer	1.78e-05	0.000522	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	1.75e-05	0.000515	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GSTM1—liver cancer	1.67e-05	0.000491	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PIK3CA—liver cancer	1.59e-05	0.000467	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—MYC—liver cancer	1.59e-05	0.000467	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CYP1A1—liver cancer	1.59e-05	0.000466	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—MTHFR—liver cancer	1.48e-05	0.000434	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PPARA—liver cancer	1.45e-05	0.000426	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PIK3CA—liver cancer	1.42e-05	0.000417	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—liver cancer	1.31e-05	0.000385	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—TP53—liver cancer	1.31e-05	0.000384	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—AKT1—liver cancer	1.3e-05	0.000382	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PIK3CG—liver cancer	1.24e-05	0.000365	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CPT1B—liver cancer	1.21e-05	0.000356	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GLUL—liver cancer	1.21e-05	0.000356	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PPARG—liver cancer	1.2e-05	0.000352	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—NR1H4—liver cancer	1.17e-05	0.000343	CbGpPWpGaD
Capecitabine—CDA—Metabolism—AKT1—liver cancer	1.16e-05	0.00034	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GSTA3—liver cancer	1.15e-05	0.000337	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PIK3CA—liver cancer	1.14e-05	0.000333	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PIK3CD—liver cancer	1.09e-05	0.000321	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ALB—liver cancer	1.08e-05	0.000317	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GSTA4—liver cancer	1.05e-05	0.000308	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	1.03e-05	0.000301	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GSTA2—liver cancer	1.02e-05	0.000301	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GSTA1—liver cancer	9.88e-06	0.00029	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—NAT2—liver cancer	9.77e-06	0.000287	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PIK3CB—liver cancer	9.53e-06	0.000279	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	9.4e-06	0.000276	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ALDOB—liver cancer	9.37e-06	0.000275	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—AKT1—liver cancer	9.27e-06	0.000272	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CRABP1—liver cancer	8.94e-06	0.000262	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	8.05e-06	0.000236	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—HPGDS—liver cancer	7.81e-06	0.000229	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	7.77e-06	0.000228	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	7.07e-06	0.000208	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	6.98e-06	0.000205	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PSMA4—liver cancer	6.96e-06	0.000204	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PSMD10—liver cancer	6.96e-06	0.000204	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GOT2—liver cancer	6.77e-06	0.000199	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CYP2E1—liver cancer	6.37e-06	0.000187	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	6.17e-06	0.000181	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CYCS—liver cancer	5.96e-06	0.000175	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GOT1—liver cancer	5.85e-06	0.000172	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GGT1—liver cancer	5.85e-06	0.000172	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PIK3CA—liver cancer	5.81e-06	0.00017	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GSTP1—liver cancer	5.25e-06	0.000154	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—HMOX1—liver cancer	5.18e-06	0.000152	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GSTM1—liver cancer	4.83e-06	0.000142	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—AKT1—liver cancer	4.74e-06	0.000139	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CYP1A1—liver cancer	4.58e-06	0.000134	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—MTHFR—liver cancer	4.27e-06	0.000125	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PPARA—liver cancer	4.18e-06	0.000123	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	3.76e-06	0.00011	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PIK3CG—liver cancer	3.58e-06	0.000105	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PPARG—liver cancer	3.46e-06	0.000101	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PIK3CD—liver cancer	3.15e-06	9.24e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ALB—liver cancer	3.11e-06	9.12e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PIK3CB—liver cancer	2.75e-06	8.06e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PIK3CA—liver cancer	1.67e-06	4.91e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—AKT1—liver cancer	1.37e-06	4.01e-05	CbGpPWpGaD
